Oxidative stress in severe pulmonary hypertension (Q44710488)

5 December 2017

Oxidative stress in severe pulmonary hypertension (English)

1 reference

5 December 2017

3

1 reference

5 December 2017

Rebecca Bowers

1

1 reference

5 December 2017

Carlyne Cool

2

1 reference

5 December 2017

Rubin M Tuder

4

1 reference

5 December 2017

Matthew W Hopken

5

1 reference

5 December 2017

Sonia C Flores

6

1 reference

5 December 2017

Norbert F Voelkel

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

30 December 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

5 December 2017

1 reference

5 December 2017

169

1 reference

5 December 2017

764-769

1 reference

5 December 2017

6

1 reference

Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis

5 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Physiological functions of thioredoxin and thioredoxin reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Pulmonary hypertension and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Oxidative stress as a regulator of gene expression in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Peroxynitrite disables the tyrosine phosphorylation regulatory mechanism: Lymphocyte-specific tyrosine kinase fails to phosphorylate nitrated cdc2(6-20)NH2 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Oxidative and nitrosative events in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Arachidonate 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Levels of 8-hydroxy-2'-deoxyguanosine in cellular DNA from 12 tissues of young and old Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

Increased lipid peroxidation in patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

The arachidonate 12/15 lipoxygenases. A review of tissue expression and biologic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200301-147OC

10.1164/RCCM.200301-147OC

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference